ServiziMenu principaleHome
You are here:  > Educational Opportunities > Past events > 2019 > 6th ESO Prostate Cancer Observatory: Innovation and care in the next 12 months
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page


The European School of Oncology is pleased to announce the 6th edition of "ESO Prostate Cancer Observatory: innovation and care in the next 12 months", which will be held during the EAU19 Congress on March 15 in Barcelona.

ESO Observatories are high level sessions organised during major international congresses with the aim of providing the audience with updated and unbiased information on a given topic. An ESO Observatory lasts about one hour and concentrates on a forecast given by panel of experts of what it is expected to happen in their own field in the coming 12 months. The Panel includes distinguished clinicians and/or scientists and a patient advocate.
The forecast by each Panel Member is given in the form of take-home concise messages with 8-minute slide presentation followed by 2 minutes of discussion for each topic. The forecast will be discussed by the panel.

The Observatory will be held during the


M. Albersen, BE
F. Algaba, ES
A. Bossi, FR
A. Deschamps, BE
R. Ganzer, DE
S. Gillesen, UK
M. Graefen, DE
O. Rouviere, FR
R. Van den Bergh, NL
J. Van Moorselaar, NL

General information

Luis Carvalho
European School of Oncology
Piazza Indipendenza 2
6500 Bellinzona
Email: lcarvalho@eso.net
Tel: +41 91 820 09 58

The Observatory will be held during the EAU Annual Congress.

Fira Gran Via
Access North / Hall 8
c/ Foc 37
08038 Barcelona

Attendance is granted to all participants registered to the EAU19 Congress.
If you wish to know more about Prostate Cancer Observatories, please click HERE.



15 March

10:45   Introduction and looking back at the 2018 predictions
(EAU18 Congress)
J. Van Moorselaar, NL - A. Deschamps, BE
10:50   The urologist´s prespective on focal therapy
R. Ganzer, DE
11:00   The urologist’s perspective on surgery
M. Graefen, DE
11:10   The urologist’s perspective on active surveillance
R. Van den Bergh, NL
11:20   The imaging specialist’s perspective on MRI
O. Rouviere, FR
11:30   The pathologist’s perspective
F. Algaba, ES
11:40   The radiation oncologist’s perspective
A. Bossi, FR
11:50   The medical oncologist’s perspective
S. Gillesen, UK
12:00   The andrologist´s perspective
M. Albersen, BE
12:10   The patient’s perspective
A. Deschamps, BE
  Discussion and take-home messages